Literature DB >> 22964944

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

M T Voso, E Fabiani, L Fianchi, G Falconi, M Criscuolo, R Santangelo, P Chiusolo, S Betti, F D'Alo', S Hohaus, V De Stefano, G Leone.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22964944     DOI: 10.1038/leu.2012.267

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.

Authors:  C Y Ok; R P Hasserjian; P S Fox; F Stingo; Z Zuo; K H Young; K Patel; L J Medeiros; G Garcia-Manero; S A Wang
Journal:  Leukemia       Date:  2013-06-21       Impact factor: 11.528

2.  SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

Authors:  Emiliano Fabiani; Giulia Falconi; Luana Fianchi; Marianna Criscuolo; Giuseppe Leone; Maria Teresa Voso
Journal:  Haematologica       Date:  2014-06-06       Impact factor: 9.941

3.  The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.

Authors:  Hamish S Scott; Christopher N Hahn; Devendra K Hiwase; Deepak Singhal; Li Yan A Wee; Monika M Kutyna; Rakchha Chhetri; Joel Geoghegan; Andreas W Schreiber; Jinghua Feng; Paul P-S Wang; Milena Babic; Wendy T Parker; Smita Hiwase; Suzanne Edwards; Sarah Moore; Susan Branford; Teodora Kuzmanovic; Nimit Singhal; Raghu Gowda; Anna L Brown; Peer Arts; Luen B To; Peter G Bardy; Ian D Lewis; Richard J D'Andrea; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2019-05-14       Impact factor: 11.528

4.  Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Authors:  M T Voso; E Fabiani; Z Zang; L Fianchi; G Falconi; A Padella; M Martini; S Li Zhang; R Santangelo; L M Larocca; M Criscuolo; A La Brocca; I Cutcutache; S Rozen; G Simonetti; M Manfrini; G Martinelli; S Hohaus; G Leone; P Tan; D G Tenen
Journal:  Blood Cancer J       Date:  2015-07-03       Impact factor: 11.037

5.  Clonal evolution in therapy-related neoplasms.

Authors:  Emiliano Fabiani; Giulia Falconi; Luana Fianchi; Marianna Criscuolo; Tiziana Ottone; Laura Cicconi; Stefan Hohaus; Simona Sica; Massimiliano Postorino; Antonino Neri; Marta Lionetti; Giuseppe Leone; Francesco Lo-Coco; Maria Teresa Voso
Journal:  Oncotarget       Date:  2017-02-14

Review 6.  Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy.

Authors:  Pellegrino Musto; Vittorio Simeon; Roberto Guariglia; Gabriella Bianchino; Vitina Grieco; Filomena Nozza; Francesco La Rocca; Gioacchino Marziano; Anna Vittoria Lalinga; Emiliano Fabiani; Maria Teresa Voso; Patrizia Scaravaglio; Cristina Mecucci; Giovanni D'Arena
Journal:  Onco Targets Ther       Date:  2014-06-13       Impact factor: 4.147

Review 7.  Therapy-related myeloid neoplasms: clinical perspectives.

Authors:  Luana Fianchi; Marianna Criscuolo; Emiliano Fabiani; Giulia Falconi; Alessio Maria Edoardo Maraglino; Maria Teresa Voso; Livio Pagano
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147

Review 8.  Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Cancers (Basel)       Date:  2020-08-26       Impact factor: 6.639

Review 9.  Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.

Authors:  Ibolya Czegle; Austin L Gray; Minjing Wang; Yan Liu; Jun Wang; Edina A Wappler-Guzzetta
Journal:  Life (Basel)       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.